News & Videos - TITAN PHARMACEUTICALS INC. - Page 2

...

Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 30, 2020 SOUTH SAN FRANCISCO, Calif. , Nov. 30, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern Time on Monday , November 30, 2020. The Company's stockholders approved the reverse stock split at...

...

...

...

Thinking about buying stock in Nio, Titan Pharmaceuticals, Zomedica Corp, Gevo Inc, or Transocean? PR Newswire NEW YORK, Nov. 23, 2020 NEW YORK , Nov. 23, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, TTNP, ZOM, GEVO, and RIG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. NIO:...

...

...

...

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 SOUTH SAN FRANCISCO, Calif. , Nov. 16, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financial results for the third quarter ended September 30, 2020 and provided an update on its business. Third Quarter 2020 and Recent Highlights In September 2020 , the Company completed a registered direct offering, resulting in...

...

...

...

...

...

Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT Pharma's Kappa Opioid Agonist Peptide, JT-09 PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 2, 2020 SOUTH SAN FRANCISCO, Calif. , Nov. 2, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced the completion of its agreement to settle all of its debt obligations with Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A ("Molteni") and Horizon Credit LLC II ("Horizon"), as well...

...

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering PR Newswire SOUTH SAN FRANCISCO, Calif., Oct. 28, 2020 SOUTH SAN FRANCISCO, Calif. , Oct. 28, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of common stock. Gross proceeds,...

Titan Pharmaceuticals Enters Into Definitive Agreement To Acquire JT Pharma's Kappa Opioid Agonist Peptide, JT-09 - Titan to Develop JT-09 Implant, Using its ProNeura® Long-Term, Continuous Drug Delivery Technology, for the Treatment of Chronic Pruritus - PR Newswire SOUTH SAN FRANCISCO, Calif., Oct. 28, 2020 SOUTH SAN FRANCISCO, Calif. , Oct. 28, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced that it has entered into a definitive asset purchase agreement (the...

...